Clinical Trial Update: Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma

View source ↗

Summary

This clinical trial update reports real-world effectiveness and safety of glofitamab in patients with primary refractory and early relapsed diffuse large B-cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Columvi (glofitamab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: DLBCL - Diffuse Large B Cell Lymphoma | Status: NOT_YET_RECRUITING